{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T07:12:07Z","timestamp":1785222727420,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"am","delay-in-days":329,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013226","name":"Les Laboratories Pierre Fabre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014732","name":"Neurofibromatosis Therapy Acceleration Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014865","name":"Fondation Maladies Rares","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006431","name":"Canc\u00e9rop\u00f4le Ile de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.trsl.2023.06.003","type":"journal-article","created":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T02:10:18Z","timestamp":1686967818000},"page":"16-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Topical delivery of mitogen-activated protein kinase inhibitor binimetinib prevents the development of cutaneous neurofibromas in neurofibromatosis type 1 mutant mice"],"prefix":"10.1016","volume":"261","author":[{"given":"Fanny","family":"Coulpier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernelle","family":"Pulh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layna","family":"Oubrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Naudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fertitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Gregoire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Bocquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Wolkenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna J.","family":"Radomska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7381-6770","authenticated-orcid":false,"given":"Piotr","family":"Topilko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.trsl.2023.06.003_bib0001","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am J Med Genet A"},{"issue":"1","key":"10.1016\/j.trsl.2023.06.003_bib0002","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1038\/nrdp.2017.4","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.trsl.2023.06.003_bib0003","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams","year":"2009","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.trsl.2023.06.003_bib0004","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/humu.21387","article-title":"Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH","volume":"32","author":"Garcia-Linares","year":"2011","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.trsl.2023.06.003_bib0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1172-6-18","article-title":"Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France","volume":"6","author":"Duong","year":"2011","journal-title":"Orphanet J Rare Dis"},{"issue":"39","key":"10.1016\/j.trsl.2023.06.003_bib0006","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1038\/s41388-021-01979-z","article-title":"Tumorigenesis in neurofibromatosis type 1: role of the microenvironment","volume":"40","author":"Jiang","year":"2021","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.trsl.2023.06.003_bib0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40478-020-01103-4","article-title":"Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing","volume":"9","author":"Brosseau","year":"2021","journal-title":"Acta Neuropathologica Commun"},{"issue":"2","key":"10.1016\/j.trsl.2023.06.003_bib0008","first-page":"S14 S20","article-title":"The biology of cutaneous neurofibromas","volume":"91","author":"Brosseau","year":"2018","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.trsl.2023.06.003_bib0009","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/s41416-018-0073-2","article-title":"Cutaneous neurofibromas in the genomics era: current understanding and open questions","volume":"118","author":"Allaway","year":"2018","journal-title":"Brit J Cancer"},{"issue":"39","key":"10.1016\/j.trsl.2023.06.003_bib0010","doi-asserted-by":"crossref","first-page":"30740","DOI":"10.1074\/jbc.M001702200","article-title":"Single cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma schwann cells but not fibroblasts*","volume":"275","author":"Sherman","year":"2000","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.trsl.2023.06.003_bib0011","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000337548","article-title":"Psychological burden in adult neurofibromatosis type 1 patients: impact of disease visibility on body image","volume":"224","author":"Granstr\u00f6m","year":"2012","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.trsl.2023.06.003_bib0012","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(01)00245-8","article-title":"NF1 tumor suppressor gene function narrowing the GAP","volume":"104","author":"Cichowski","year":"2001","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.trsl.2023.06.003_bib0013","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/neuonc\/noac146","article-title":"Management of neurofibromatosis type 1-associated plexiform neurofibromas","volume":"24","author":"Fisher","year":"2022","journal-title":"Neuro-oncology"},{"issue":"11","key":"10.1016\/j.trsl.2023.06.003_bib0014","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/neuonc\/noac165","article-title":"MEK inhibitors for neurofibromatosis type 1 manifestations: clinical evidence and consensus","volume":"24","author":"de","year":"2022","journal-title":"Neuro-oncology"},{"issue":"26","key":"10.1016\/j.trsl.2023.06.003_bib0015","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa1605943","article-title":"Activity of selumetinib in neurofibromatosis type 1\u2013related plexiform neurofibromas","volume":"375","author":"Eva","year":"2016","journal-title":"New Engl J Med"},{"issue":"15","key":"10.1016\/j.trsl.2023.06.003_bib0016","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1912735","article-title":"Selumetinib in children with inoperable plexiform neurofibromas","volume":"382","author":"Gross","year":"2020","journal-title":"New Engl J Med"},{"issue":"1","key":"10.1016\/j.trsl.2023.06.003_bib0017","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI60578","article-title":"MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors","volume":"123","author":"Jessen","year":"2012","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.trsl.2023.06.003_bib0018","doi-asserted-by":"crossref","first-page":"130 147","DOI":"10.1158\/2159-8290.CD-18-0156","article-title":"Cellular origin, tumor progression, and pathogenic mechanisms of cutaneous neurofibromas revealed by mice with nf1knockout in boundary cap cells","volume":"9","author":"Radomska","year":"2019","journal-title":"Cancer Discov"},{"issue":"2","key":"10.1016\/j.trsl.2023.06.003_bib0019","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.stemcr.2015.06.005","article-title":"Boundary caps give rise to neurogenic stem cells and terminal glia in the skin","volume":"5","author":"Gresset","year":"2015","journal-title":"Stem Cell Rep"},{"issue":"2","key":"10.1016\/j.trsl.2023.06.003_bib0020","first-page":"S5 S13","article-title":"Cutaneous neurofibromas","volume":"91","author":"Ortonne","year":"2018","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.trsl.2023.06.003_bib0021","first-page":"789","article-title":"Advanced characterization of imiquimod-induced psoriasis-like mouse model","volume":"12","author":"Jabeen","year":"2020","journal-title":"Pharm"},{"issue":"1","key":"10.1016\/j.trsl.2023.06.003_bib0022","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/187221312798889301","article-title":"Imiquimod 5% cream use in dermatology, side effects and recent patents","volume":"6","author":"Cantisani","year":"2011","journal-title":"Recent Patents Inflamm Allergy Drug Discov"},{"issue":"3","key":"10.1016\/j.trsl.2023.06.003_bib0023","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jid.2016.10.024","article-title":"The snowballing literature on imiquimod-induced skin inflammation in mice: a critical appraisal","volume":"137","author":"Hawkes","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.trsl.2023.06.003_bib0024","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12918-015-0187-6","article-title":"Regulation of ERK-MAPK signaling in human epidermis","volume":"9","author":"Cursons","year":"2015","journal-title":"Bmc Syst Biol"},{"issue":"1","key":"10.1016\/j.trsl.2023.06.003_bib0025","first-page":"215","article-title":"Role of mitogen-activated protein kinases in the formation of hypertrophic scar with model of lipopolysaccharide stimulated skin fibroblast cells","volume":"34","author":"Wang","year":"2017","journal-title":"Pak J Med Sci"},{"issue":"5","key":"10.1016\/j.trsl.2023.06.003_bib0026","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/ajcp\/aqaa186","article-title":"A clinicopathologic study on the role of estrogen, progesterone, and their classical and nonclassical receptors in cutaneous neurofibromas of individuals with neurofibromatosis 1","volume":"155","author":"Rozza-de-Menezes","year":"2020","journal-title":"Am J Clin Pathol"},{"issue":"1-2","key":"10.1016\/j.trsl.2023.06.003_bib0027","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11010-017-3227-2","article-title":"The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1+\/\u2212 or NF1\u2212\/\u2212 genotype derived from human cutaneous neurofibromas","volume":"444","author":"Pennanen","year":"2018","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.trsl.2023.06.003_bib0028","doi-asserted-by":"crossref","first-page":"S1002","DOI":"10.4137\/CPath.S1002","article-title":"Progesterone and estrogen receptors in neurofibromas of patients with NF1","volume":"1","author":"Geller","year":"2008","journal-title":"Clin Med Insights Pathol"},{"issue":"1","key":"10.1016\/j.trsl.2023.06.003_bib0029","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1203\/PDR.0b013e31817445b8","article-title":"Schwann cells from human neurofibromas show increased proliferation rates under the influence of progesterone","volume":"64","author":"Overdiek","year":"2008","journal-title":"Pediatr Res"},{"issue":"2","key":"10.1016\/j.trsl.2023.06.003_bib0030","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/dvdy.21430","article-title":"Influence of hormones and hormone metabolites on the growth of schwann cells derived from embryonic stem cells and on tumor cell lines expressing variable levels of neurofibromin","volume":"237","author":"Roth","year":"2008","journal-title":"Dev Dyn"},{"issue":"8","key":"10.1016\/j.trsl.2023.06.003_bib0031","doi-asserted-by":"crossref","first-page":"758","DOI":"10.4161\/cbt.10.8.12878","article-title":"Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells","volume":"10","author":"Li","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.trsl.2023.06.003_bib0032","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.physbeh.2016.12.038","article-title":"Social context-dependent relationships between mouse dominance rank and plasma hormone levels","volume":"171","author":"Williamson","year":"2017","journal-title":"Physiol Behav"},{"issue":"4","key":"10.1016\/j.trsl.2023.06.003_bib0033","first-page":"RA136","article-title":"Testosterone and aggressiveness","volume":"11","author":"Giammanco","year":"2003","journal-title":"Medical Sci Monit"},{"issue":"8","key":"10.1016\/j.trsl.2023.06.003_bib0034","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.cell.2021.03.002","article-title":"Nonpeptidergic neurons suppress mast cells via glutamate to maintain skin homeostasis","volume":"184","author":"Zhang","year":"2021","journal-title":"Cell"},{"issue":"7465","key":"10.1016\/j.trsl.2023.06.003_bib0035","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nature12479","article-title":"Bacteria activate sensory neurons that modulate pain and inflammation","volume":"501","author":"Chiu","year":"2013","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.trsl.2023.06.003_bib0036","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.cell.2019.06.022","article-title":"Cutaneous TRPV1+ neurons trigger protective innate type 17 anticipatory immunity","volume":"178","author":"Cohen","year":"2019","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.trsl.2023.06.003_bib0037","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.immuni.2015.08.016","article-title":"Nociceptive sensory fibers drive interleukin-23 production from CD301b+ dermal dendritic cells and drive protective cutaneous immunity","volume":"43","author":"Kashem","year":"2015","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.trsl.2023.06.003_bib0038","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.cell.2018.04.006","article-title":"Blocking neuronal signaling to immune cells treats streptococcal invasive infection","volume":"173","author":"Pinho-Ribeiro","year":"2018","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.trsl.2023.06.003_bib0039","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/s41590-019-0493-z","article-title":"House dust mites activate nociceptor-mast cell clusters to drive type 2 skin inflammation","volume":"20","author":"Serhan","year":"2019","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.trsl.2023.06.003_bib0040","article-title":"Schwann cells: development and role in nerve repair","volume":"7","author":"Jessen","year":"2015","journal-title":"Csh Perspect Biol"},{"issue":"12","key":"10.1016\/j.trsl.2023.06.003_bib0041","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168227","article-title":"Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor","volume":"133","author":"Jiang","year":"2023","journal-title":"J Clin Invest"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524423001056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524423001056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:48:17Z","timestamp":1761828497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524423001056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":41,"alternative-id":["S1931524423001056"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2023.06.003","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical delivery of mitogen-activated protein kinase inhibitor binimetinib prevents the development of cutaneous neurofibromas in neurofibromatosis type 1 mutant mice","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2023.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}